Benign Growth For Bayer Aktiengesellschaft (ETR:BAYN) Underpins Stock's 25% Plummet
Nov 21
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies11
- 7D-7.0%
- 3M-21.1%
- 1Y-21.6%
- YTD-17.0%
Over the last 7 days, the Pharma industry has dropped 6.1%, driven by Merck KGaA declining 7.4%. Meanwhile, Dermapharm Holding actually outperformed within the industry, gaining 12% in the last week. Overall the industry is down 22% in 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | €81.8b | €69.2b | €2.0b | 21.9x | 40.4x | 1.2x |
| Sat, 19 Oct 2024 | €99.9b | €69.4b | €1.6b | 21.1x | 64x | 1.4x |
| Mon, 16 Sep 2024 | €101.9b | €69.3b | €1.5b | 24.7x | 69.2x | 1.5x |
| Wed, 14 Aug 2024 | €100.5b | €69.3b | €1.5b | 30.5x | 69x | 1.4x |
| Fri, 12 Jul 2024 | €95.4b | €69.2b | -€303,627,757.00 | 29.4x | -314.1x | 1.4x |
| Sun, 09 Jun 2024 | €104.7b | €69.2b | -€328,028,608.00 | 20.5x | -319.1x | 1.5x |
| Tue, 07 May 2024 | €96.1b | €70.0b | -€63,275,489.99 | 20x | -1518.8x | 1.4x |
| Thu, 04 Apr 2024 | €99.1b | €70.0b | -€34,208,180.00 | 20.9x | -2896.1x | 1.4x |
| Sat, 02 Mar 2024 | €99.2b | €70.6b | -€650,504,143.00 | 19.8x | -152.5x | 1.4x |
| Mon, 29 Jan 2024 | €102.2b | €70.6b | -€647,396,793.00 | 22.3x | -157.9x | 1.4x |
| Wed, 27 Dec 2023 | €96.3b | €70.6b | -€650,606,256.00 | 19.4x | -148x | 1.4x |
| Fri, 24 Nov 2023 | €105.0b | €70.6b | -€653,407,256.00 | 19.7x | -160.7x | 1.5x |
| Sun, 22 Oct 2023 | €108.0b | €72.1b | €4.7b | 18.1x | 23.1x | 1.5x |
| Tue, 19 Sep 2023 | €120.6b | €72.1b | €4.7b | 21.7x | 25.8x | 1.7x |
| Thu, 17 Aug 2023 | €123.0b | €72.1b | €4.7b | 22.6x | 26.2x | 1.7x |
| Sat, 15 Jul 2023 | €117.4b | €74.1b | €6.5b | 18.2x | 18.2x | 1.6x |
| Mon, 12 Jun 2023 | €126.6b | €74.1b | €6.4b | 22.6x | 19.8x | 1.7x |
| Wed, 10 May 2023 | €131.0b | €74.2b | €7.6b | 21.2x | 17.3x | 1.8x |
| Fri, 07 Apr 2023 | €139.0b | €74.1b | €7.6b | 19.7x | 18.2x | 1.9x |
| Sun, 05 Mar 2023 | €137.0b | €74.2b | €7.7b | 18.5x | 17.9x | 1.8x |
| Tue, 31 Jan 2023 | €142.7b | €72.8b | €8.4b | 15x | 17.1x | 2x |
| Thu, 29 Dec 2022 | €129.3b | €72.8b | €8.4b | 14.9x | 15.4x | 1.8x |
| Sat, 26 Nov 2022 | €134.0b | €72.8b | €8.4b | 17x | 16x | 1.8x |
| Mon, 24 Oct 2022 | €121.1b | €70.5b | €7.8b | 13.1x | 15.6x | 1.7x |
| Wed, 21 Sep 2022 | €125.8b | €70.5b | €7.8b | 15.3x | 16.2x | 1.8x |
| Fri, 19 Aug 2022 | €135.7b | €70.5b | €7.8b | 13.7x | 17.4x | 1.9x |
| Sun, 17 Jul 2022 | €133.9b | €67.8b | €5.6b | 23.8x | 23.8x | 2x |
| Tue, 14 Jun 2022 | €138.2b | €67.8b | €5.6b | 22.9x | 24.6x | 2x |
| Thu, 12 May 2022 | €134.1b | €67.2b | €5.5b | 24.1x | 24.4x | 2x |
| Sat, 09 Apr 2022 | €150.7b | €64.8b | €4.2b | 29.6x | 35.8x | 2.3x |
| Mon, 07 Mar 2022 | €130.4b | €63.7b | €3.4b | 27.9x | 38x | 2x |
| Wed, 02 Feb 2022 | €143.1b | €63.1b | €3.1b | 31.8x | 46.7x | 2.3x |
| Fri, 31 Dec 2021 | €150.3b | €63.1b | €3.1b | 36x | 49x | 2.4x |
| Sun, 28 Nov 2021 | €146.7b | €63.1b | €3.1b | 36.9x | 47.9x | 2.3x |
Price to Earnings Ratio
47.9x
Current Industry PE
- Investors are pessimistic on the German Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 41.0x which is lower than its 3-year average PE of 166x.
- The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 13% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.41% | |
| Healthcare | -3.73% | |
| Pharma | -6.98% | |
| Pharma | -6.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DMP Dermapharm Holding | €36.90 | 17.9% +€301.5m | -8.2% | PE21.9x | |
| 93M1 MPH Health Care | €24.20 | 4.3% +€4.3m | 58.2% | PE0.9x | |
| HIGH Cantourage Group | €4.56 | 7.5% +€4.0m | -43.9% | PE257.1x | |
| APPH Apontis Pharma | €9.90 | 1.6% +€1.3m | 164.0% | PS2x | |
| 27N0 Cannovum Cannabis | €0.58 | 2.6% +€6.9k | -75.7% | n/a |
